MEN1 and neuroendocrine neoplasm: Previous studies have shown that the MEN1 E235K variant was established as an oncogenic driver in gastroenteropancreatic neuroendocrine tumors, where mutant menin underwent enhanced proteasomal‐independent degradation, ablating its tumor‐suppressive activity.[43] In a family with Li‐Fraumeni Syndrome, Lee et al.